Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Julphar
Merck
McKinsey
US Department of Justice
Harvard Business School
Cantor Fitzgerald
Daiichi Sankyo
Johnson and Johnson
Dow

Generated: October 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,344,006

« Back to Dashboard

Which drugs does patent 8,344,006 protect, and when does it expire?


Patent 8,344,006 protects TREANDA and is included in one NDA. There have been two Paragraph IV challenges on Treanda.

Protection for TREANDA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 8,344,006

Title:Liquid formulations of bendamustine
Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
Inventor(s): Drager; Anthony S. (Thorndale, PA), Labell; Rachel Y. (Coatesville, PA), Patel; Piyush R. (Wallingford, PA)
Assignee: Cephalon, Inc. (Frazer, PA)
Application Number:13/362,430
Patent Claim Types:
see list of patent claims
Formulation; Compound; Composition; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Cephalon
TREANDA
bendamustine hydrochloride
SOLUTION;IV (INFUSION)022249-003Sep 13, 2013RXYesYes► Subscribe► SubscribeY
Cephalon
TREANDA
bendamustine hydrochloride
SOLUTION;IV (INFUSION)022249-004Sep 13, 2013RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Fish and Richardson
Queensland Health
McKesson
Cipla
Citi
Healthtrust
Colorcon
Covington
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot